Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity
- PMID: 21158371
- DOI: 10.3928/01913913-20100818-09
Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity
Abstract
Trial of intravitreal bevacizumab injection in 7 eyes of 4 infants with continued retinopathy of prematurity progression despite previous laser therapy was reported. Six of the eyes benefited from the therapy. Intravitreal bevacizumab injection may be an alternative therapy in progressive stage 3 retinopathy of prematurity despite laser photocoagulation.
Copyright 2010, SLACK Incorporated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
